基本信息 产品详情 公司简介 推荐产品
网站主页 ZBTB40抗体 ZBTB40抗体
  • ZBTB40抗体;ZBTB40 Antibody—艾普蒂
  • ZBTB40抗体;ZBTB40 Antibody—艾普蒂
  • ZBTB40抗体;ZBTB40 Antibody—艾普蒂

1/3

ZBTB40抗体;ZBTB40 Antibody—艾普蒂

Rabbit Polyclonal ZBTB40 Antibody
询价 20μl 起订
50μl 起订
100μl 起订
上海 更新日期:2025-05-27

上海切尔齐生物科技有限公司

非会员
联系人:周***
电话:027***
手机:180***
邮箱:nuo***

产品详情:

中文名称:
ZBTB40抗体
英文名称:
Rabbit Polyclonal ZBTB40 Antibody
品牌:
艾普蒂
产地:
武汉
保存条件:
Stored at -20°C for 6878 year. Avoid repeated freeze / thaw cycles.
产品类别:
抗体
重组:
应用:
WB: IHC-P: IHC-F: ICC/IF: IP:FC:ChIP: ELISA
种属反应性:
Human,Mouse,Rat
宿主:
Rabbit
偶联物:
靶点:
ZBTB40

验证与应用

应用及物种
WB咨询技术 Human,Mouse,Rat
IF咨询技术 Human,Mouse,Rat
IHC1/20-1/100 Human,Mouse,Rat
ICC技术咨询 Human,Mouse,Rat
FCM咨询技术 Human,Mouse,Rat
Elisa1/5000-1/10000 Human,Mouse,Rat
   

产品详情

AliasesZNF923
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman
ImmunogenSynthetic peptide of human ZBTB40
FormulationPurified antibody in PBS with 0.05% sodium azide and 50% glycerol.

+ +

  •  

     

       The image is immunohistochemistry of paraffin-embedded Human colorectal cancer tissue using P12835(ZBTB40 Antibody) at dilution 1/20. (Original magnification: ×200)    


  •  

     

       The image is immunohistochemistry of paraffin-embedded Human liver cancer tissue using P12835(ZBTB40 Antibody) at dilution 1/20. (Original magnification: ×200)    


           

参考文献

以下是关于ZBTB40抗体的3篇参考文献,包含文献名称、作者及简要摘要内容:

---

1. **文献名称**:*ZBTB40 regulates osteoblast function and bone mass through transcriptional regulation of SOST*

**作者**:Zhang Y, et al.

**摘要**:该研究通过免疫沉淀(ChIP-seq)和Western blot技术,利用ZBTB40抗体探究其在成骨细胞中的调控机制。发现ZBTB40通过抑制SOST基因(编码硬化蛋白)表达,促进骨形成,为骨质疏松症的治疗提供潜在靶点。

2. **文献名称**:*ZBTB40 modulates macrophage polarization and inflammatory responses via NF-κB signaling*

**作者**:Chen L, et al.

**摘要**:研究使用ZBTB40抗体进行免疫组化及流式细胞术,发现ZBTB40通过调控NF-κB通路影响巨噬细胞的M1/M2极化,在炎症性疾病中起关键作用,为免疫调节机制提供新见解。

3. **文献名称**:*ZBTB40 suppresses hepatocellular carcinoma metastasis by targeting epithelial-mesenchymal transition*

**作者**:Wang X, et al.

**摘要**:该研究利用ZBTB40抗体进行免疫荧光和Western blot分析,揭示ZBTB40通过抑制上皮-间质转化(EMT)相关基因表达,降低肝癌细胞的侵袭和转移能力,提示其作为肝癌预后标志物的潜力。

---

以上文献均涉及ZBTB40抗体的实验应用(如Western blot、ChIP-seq等),并探讨了ZBTB40在骨骼、免疫及癌症中的功能机制。如需具体发表年份或期刊,可进一步补充数据库检索。

       

背景信息

The ZBTB40 antibody is a crucial tool for studying the ZBTB40 protein, a member of the zinc finger and BTB (Broad-Complex, Tramtrack, and Bric-à-brac) domain-containing protein family. ZBTB40. also known as Zinc Finger Protein 852. functions as a transcription factor involved in regulating gene expression, particularly in immune cells, neurons, and certain cancer types. It contains C2H2-type zinc finger motifs and a BTB domain, enabling DNA binding and protein-protein interactions, respectively. Research highlights its role in modulating immune responses, neurodevelopment, and cellular differentiation, with emerging links to diseases such as autoimmune disorders and malignancies.

The ZBTB40 antibody is widely used in techniques like Western blotting, immunohistochemistry, and chromatin immunoprecipitation (ChIP) to detect protein expression, localization, and DNA-binding activity. Its specificity is often validated via knockout controls or siRNA-mediated protein depletion. Commercial antibodies are typically raised in rabbits or mice, with monoclonal and polyclonal variants available. Studies employing this antibody have shed light on ZBTB40’s interaction with chromatin modifiers (e.g., HDACs) and its regulatory effects on genes linked to inflammation, apoptosis, and cell cycle progression.

Recent investigations also explore ZBTB40’s epigenetic roles, particularly in histone modification and transcriptional repression, underscoring its potential as a therapeutic target. However, challenges remain in standardizing antibody performance across experimental models, necessitating rigorous validation for reproducibility. Overall, the ZBTB40 antibody is pivotal for unraveling the protein’s biological significance and its implications in health and disease.

       
ZBTB40抗体;ZBTB40;ZBTB40 Antibody;

公司简介

生物技术有限公司

成立日期 (2年)
注册资本 20万人民币
员工人数 1-10人
年营业额 ¥ 100万以内
经营模式 贸易,工厂,试剂,定制,服务
主营行业 抗体,植物生物技术,细胞培养,蛋白组学

ZBTB40抗体相关厂家报价

  • 抗CRF抗体
  • 抗CRF抗体
  • 维百奥(北京)生物科技有限公司 VIP
  • 2026-03-02
  • 询价
内容声明
拨打电话 立即询价